表 3.

2型pRCC患者预后相关的单因素和多因素分析

Univariate and multifactorial analysis of the prognosis associated with type 2 pRCC patients

Items	Univariate analysis			Multifactorial analysis (P)
	HR	95%CI	P
pRCC, papillary renal cell carcinoma; BMI, body mass index; HR, hazard ratio; CI, confidence interval.
Gender (Male/Female)	0.296	0.038-2.295	0.215
BMI (>24.9 kg/m2/≤24.9 kg/m2)	0.913	0.290-2.871	0.876
Tumor location (Left/Right)	0.799	0.256-2.498	0.700
Surgical method (Radical/Partial)	3.316	0.886-12.417	0.055	0.100
pT stages (T3-4/ T1-2)	12.495	2.605-59.929	< 0.001	0.584
Nuclear grade (Ⅲ-Ⅳ / Ⅰ-Ⅱ)	1.333	0.391-4.541	0.641
Vascular cancer embolism (Yes/No)	34.301	3.983-295.376	< 0.001	0.001
Lymph node metastasis (Yes/No)	15.257	2.767-84.121	< 0.001	0.558
Adrenal metastasis (Yes/No)	4.009	0.488-32.905	0.274